Lawrence Blatt - Oct 25, 2023 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role
Chief Executive Officer, Director
Signature
/s/ Lucinda Y. Quan, as attorney-in fact for Lawrence M. Blatt
Stock symbol
ALGS
Transactions as of
Oct 25, 2023
Transactions value $
$500,000
Form type
4
Date filed
10/27/2023, 04:14 PM
Previous filing
Sep 12, 2023
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALGS Common Stock Award $462K +610K +49.32% $0.76 1.85M Oct 25, 2023 Direct
holding ALGS Common Stock 113K Oct 25, 2023 See footnote F1
holding ALGS Common Stock 123K Oct 25, 2023 See footnote F2
holding ALGS Common Stock 18.5K Oct 25, 2023 See footnote F3
holding ALGS Common Stock 18.5K Oct 25, 2023 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALGS Warrants (Right to Buy) Award $38.1K +305K $0.13* 305K Oct 25, 2023 Common Stock 305K $0.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Lawrence M. Blatt Living Trust dated 8/27/14.
F2 PENSCO Trust Company LLC Custodian FBO Dr. Lawrence Blatt IRA.
F3 Zachary David Blatt Irrevocable Trust dated 8/24/14.
F4 Zoe Anne Blatt Irrevocable Trust dated 8/24/14.